Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978130 · ClinicalTrials.gov registry record · NA
Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT03978130 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 400 participants.
The verdict
NCT03978130, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
RESILIENT is a phase II, multi-center, prospective, pragmatic randomized clinical trial with blinded assessment of the primary endpoint. This study aims to evaluate whether mHealth-CR improves functional capacity in older adults (age ≥65) with IHD compared with standard traditional cardiac rehabilitation care. A total of 400 eligible patients will be randomized in 3:1 manner to mHealth-CR versus usual care for assessment of primary endpoint. Enrollment will occur over approximately 42 months with an expected minimum of 3 months follow-up per participant.
Interventions
- OTHER mHealth-CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03978130
The ClinicalTrials.gov registry entry for NCT03978130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mHealth-CR is the first listed.
NCT03978130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03978130 about?
NCT03978130 is a clinical study titled "Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease". RESILIENT is a phase II, multi-center, prospective, pragmatic randomized clinical trial with blinded assessment of the primary endpoint. This study aims to evaluate whether mHealth-CR improves functional capacity in older adults (age ≥65) with IHD compared with standard traditional cardiac rehabilit...
What is the current status of trial NCT03978130?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2020-01-09. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03978130?
The interventions under investigation include: mHealth-CR (OTHER).
Who is sponsoring clinical trial NCT03978130?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.